Tempus AI (TEM) Gross Margin (2023 - 2026)
Tempus AI's (TEM) quarterly Gross Margin came in at 71.7% in Q2 2026, up 341.0% year-over-year from 16.26% in Q2 2025, and up 0.99% quarter-over-quarter from 71.0% in Q1 2026.
Analysis
Tempus AI (TEM) Gross Margin (2023 - 2026) Analysis & Trends
Tempus AI (TEM) has reported Gross Margin for 4 consecutive years, with 71.7% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin rose 341.0% year-over-year to 71.7% in Q2 2026; TTM through Jun 2026 was 71.32%, a 355.0% increase from a year earlier, with the FY2025 full-year figure at 69.64%, up 475.0% from the prior year.
- Gross Margin was 71.7% for Q2 2026 at Tempus AI, up from 71.0% in the prior quarter.
- Over five years, Gross Margin peaked at 71.97% in Q4 2025 and troughed at 58.83% in Q2 2024.
- A 4-year average of 67.3% and a median of 66.85% in 2025 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin tumbled 570 bps in 2024 and surged 946 bps in 2025, its largest moves.
- Over 4 years, Gross Margin stood at 65.89% in 2023, then climbed by 5 bps to 69.01% in 2024, then advanced by 4 bps to 71.97% in 2025, then decreased by 0 bps to 71.7% in 2026.
- The last three Gross Margin figures came in at 71.7% (Q2 2026), 71.0% (Q1 2026), and 71.97% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 47.13 Bn | 46.03 Bn | 486.15 Mn | 64.58% |
| 2 | Labcorp Holdings | 26.44 Bn | 26.32 Bn | 1.11 Bn | 29.80% |
| 3 | Quest Diagnostics | 26.16 Bn | 25.84 Bn | 1.03 Bn | 33.75% |
| 4 | Guardant Health | 21.57 Bn | 20.51 Bn | 219.03 Mn | 65.39% |
| 5 | Tempus AI | 11.32 Bn | 10.51 Bn | 274.25 Mn | 71.70% |
| 6 | Caris Life Sciences | 7.08 Bn | 6.29 Bn | 182.38 Mn | 69.16% |
| 7 | Sotera Health | 5.39 Bn | 5.04 Bn | 177.96 Mn | 55.38% |
| 8 | BillionToOne | 4.65 Bn | 4.11 Bn | 77.11 Mn | 70.45% |
| 9 | iRhythm Holdings | 4.05 Bn | 3.46 Bn | 163.21 Mn | 72.80% |
| 10 | Adaptive Biotechnologies | 3.86 Bn | 3.53 Bn | 51.39 Mn | 71.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.70% |
| Mar 31, 2026 | 71.00% |
| Dec 31, 2025 | 71.97% |
| Sep 30, 2025 | 70.48% |
| Jun 30, 2025 | 68.29% |
| Mar 31, 2025 | 66.85% |
| Dec 31, 2024 | 69.01% |
| Sep 30, 2024 | 66.77% |
| Jun 30, 2024 | 58.83% |
| Mar 31, 2024 | 63.77% |
| Dec 31, 2023 | 65.89% |
| Sep 30, 2023 | 65.79% |
| Jun 30, 2023 | 64.54% |